본문 바로가기
KERD
논문KCI 등재

N-butyl-N-(4-hydroxybutyl)nitrosamine으로 유도된 흰쥐의 방광암 발생과정에서 Survivin, HSP90, Bcl-2, Bax 단백의 발현

Expression of Survivin, HSP90, Bcl-2 and Bax Proteins in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced RatBladder Carcinogenesis

이태진|권귀영|홍순억|이상대|박성웅
대한병리학회|2006.10|Journal of Pathology and Translational Medicine|제40권 제5호|pp. 333-338

1

조회

0

다운로드

1

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : Survivin belongs to the inhibitor of apoptosis family, and it has recently been found to be expressed in most solid tumors. Therefore, its expression is suggested to have prognostic significance. However, no data are available concerning the significance of survivin for the carcinogenesis of bladder cancer. Methods : In order to induce urothelial tumor in the rat urinary bladder, 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was administered to male Sprague-Dawley rats for 30 weeks. We used immunohistochemistry to investigate the expressions of survivin, HSP90, Bcl-2 and Bax in rat bladder carcinogenesis. Results : Urothelial cell hyperplasia, papilloma, non-invasive urothelial carcinoma and invasive urothelial carcinoma appeared at 5, 10, 20 and 30 weeks, respectively. The expressions of survivin and HSP90 increased sequentially from normal mucosa, hyperplasia, papilloma, non-invasive urothelial carcinoma to invasive urothelial carcinoma. The expressions of Bcl-2 and Bax did not increase, however the number of cases with more than 1 of Bcl-2/Bax expression ratio increased sequentially during the progression of urothelial lesion. The expression of survivin showed a statistically significant correlation with the expression of HSP90 and the Bcl-2/Bax expression ratio. Conclusions : Our findings suggest that survivin may be involved in the carcinogenesis of rat bladder and its expression is correlated with the expression of HSP90 and the Bcl-2/Bax expression ratio.

참고문헌 (30)

  1. "Bladder cancer", 12, pp.255~259 (2000)
  2. "Prognostic markers of intravesical bacillus Calmette-Guerin therapy for multiple,high-grade,stage T1 bladdercancers", 4, pp.552~556 (1997)
  3. "Bcl-2", bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer, 1996, pp.69, 100~104
  4. "Two splic-ing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern", 495, pp.56~60 (2001)
  5. "Expression and prognostic significance of LIVIN,SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer", 14, pp.85~90 (2003)
  6. "A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma", 3, pp.917~921 (1997)
  7. "Expression and targeting of the apoptosis inhibitor,survivin,in human melanoma", 113, pp.1076~1081 (1999)
  8. "Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer", 341, pp.452~453 (1999)
  9. "Regulation of survivin function by Hsp90", 100, pp.13791~13796 (2003)
  10. "Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications", 10, pp.86~103 (2005)
  11. "Heat shock proteins:new keys to the development of cytoprotective therapies", 5, pp.267~287 (2001)
  12. "Estrogenic regulation of HSP90 kD synthesis in rat urinary bladder", 29, pp.338~344 (2001)
  13. "Heat shock protein-90,IL-6 and IL-10 in bladder cancer", 20, pp.4579~4583 (2000)
  14. "Histogenesis ofurinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats", 60, pp.401~10 (1969)
  15. "Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis", 11, pp.4740~4744 (2005)
  16. "An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7", 40, pp.1117~1123 (2001)
  17. "Survivin promotes cell proliferation in human hepatocellular carcinoma", 31, pp.1080~1085 (2000)
  18. "Survivin--a universal tumor antigen", 17, pp.669~675 (2002)
  19. "Survivin:role in normal cells and in pathological conditions", 3, pp.131~152 (2003)
  20. "Increased expression of survivin in gastric cancer patients and in first degree relatives", 87, pp.91~97 (2002)
  21. "Expression of survivin protein in human colorectal carcinogenesis", 9, pp.974~977 (2003)
  22. "Expression of survivin,a novel inhibitor of apoptosis,in superficial transitional cell carcinoma of the bladder", 171, pp.631~635 (2004)
  23. "Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence", 23, pp.3327~3331 (2003)
  24. "4-Hydroxybutyl (butyl) nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin", 26, pp.571~578 (2005)
  25. "Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer", 59, pp.235~242 (2005)
  26. "Quantitative analysis of survivin mRNA expression in urine andtumor tissue of bladder cancer patients and its potential relevancefor disease detection and prognosis", 116, pp.100~104 (2005)
  27. "Coupling apoptosis resistance to the cellular stress response:the IAP-Hsp90 connection in cancer", 3, pp.255~256 (2004)
  28. "Regulation of survivin function by Hsp90", 100, pp.13791~13796 (2003)
  29. "Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system", 97, pp.889~894 (2000)
  30. "Bcl-2 heterodimerizes invivo with a conserved homolog,Bax,that accelerates programmedcell death", 74, pp.609~19 (1993)

관련 논문AI추천

N-butyl- N-(4-hydroxybutyl)nitrosamine에 의한 흰쥐 방광암 발생 과정에서 세포주기 관련인자 단백(Cyclin D1, A, E, and B)의 발현권귀영, 김미경, 박언섭, 봉성근, 송계용, 유재형, 이태진대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제4호담낭암종에서의 p53, Heat Shock Protein 70과 TopoisomeraseIIα 의 발현김대철, 노미숙, 정진숙대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제6호신세포암종에서 Heat Shock Protein 27의 발현과 세포자멸사에 대한 연구윤길숙대한병리학회 · Journal of Pathology and Translational Medicine2006 · 제40권 제1호유방 병변의 악성 진행에 따른 Survivin 단백 발현강석진, 강창석, 유진영, 이교영, 이은정, 정지한, 정찬권, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2007 · 제41권 제4호화학적 간발암모델에서 Bisphenol A 가 간암의 전암성 및 종양성병변에 미치는 영향박기대, 임국환, 한범석한국환경보건학회 · 한국환경보건학회지2006 · 제32권 제1호유방의 침윤성 관암종에서 p21, p53 및 bcl-2 단백의 발현문형배, 윤기중, 조향정대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제6호

이 간행물의 다른 논문 (12건)

대장암에서 M30 면역 염색으로 검출된 세포 자멸사와 MSI및 임상 병리학적 특징과의 상관 관계허기영, 김활웅, 최경운, 강현정, 신동훈, 김지연, 이창훈, 이수한, 설미영, 박도윤pp. 319-325비소세포폐암종에서 Galectin-3 단백 발현의 의의신동훈, 설미영, 이민기, 강현정, 이창훈pp. 326-332Genistein 에 의한 B35 신경모세포종 세포의, 세포자멸사유도 및 세포주기 정지; p21waf1/cip1, Bax와 Bcl-2의 관련손윤경, 김정완, 강구성, Ismail A. Ismailpp. 339-347특발성 문맥압 항진증 8예의 임상 및 병리학적 분석김경모, 김경은, 임영석, 유은실pp. 348-353백서 N-nitrosomorpholine Stop Experiment시 발생하는간세포 종양과 전구병변에서의 PDGF-Rα 발현김수진, 김경태, 정진숙pp. 354-360
원문 보기